If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
368.20    -1.00 (-0.27%)
Bid:
368.20
Ask:
368.40
Spread: 0.20 (0.054%)
Market Cap: £1.95b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Hammerson Completes Refinancing Transactions

9 Oct 2024 07:00

RNS Number : 4219H
Hammerson PLC
09 October 2024
 

9 October 2024

Hammerson plc

("Hammerson" or the "Company/Group")

Hammerson completes refinancing transactions to underpin growth strategy

Following the successful issuance of its 12-year £400m bond, Hammerson sets out the final outcome of the new issuance and accompanying tender of the Company's outstanding bonds maturing in 2026 and 2028:

· 12-year £400m bond pricing confirmed on 3 October at a coupon of 5.875% representing a spread of 183 basis points over the reference gilt rate

· Strong demand led to peak order book in excess of £2.6bn (over 7x subscribed)

· The repurchase of a total of £411.6m bonds, comprising £168.4m of 6% 2026s and £243.2m of 7.25% 2028s

· An annualised net interest benefit to Hammerson of £3.6m1 per year (approximately £0.8m for the financial year ending 2024)

· This reduces weighted average gross interest from 3.8%2 to 3.6% and extends Hammerson's weighted average debt maturity from 2.9 years3 to 5.2 years

· The refinancing is largely leverage neutral; pro forma4 LTV at 30 June 2024 is 25.5% and net debt:EBITDA is 5.4x

 

Himanshu Raja, CFO of Hammerson plc, commented:

"The combined effect of our new £400m 5.875% bond maturing in 2036 and the tender of our existing short-dated sterling maturities reduces our ongoing interest costs and extends our weighted average debt maturity. The strong demand and competitive pricing are a clear recognition from investors of the strength of our portfolio, the robust balance sheet and the opportunity ahead of us."

 

1 Annualised interest benefit arises due to the weighted average interest cost on the bonds tendered (6% on 2026s and 7.87% on 2028s) being 7.1% and higher than the 5.875% coupon on the new issue, offset by the impact of new issue discounts and the reduction to interest receivable due to net cash outflows.

2 Weighted average gross interest rate at 30 June 2024 of 3.4% and pro forma for the refinancing of Dundrum in August 2024 of 3.8%.

3 Weighted average debt maturity at 30 June 2024 of 2.2 years and pro forma for the refinancing of Dundrum in August 2024 of 2.9 years. 

4 Pro forma for the tender and new issuance financing transactions and the disposal of the Group's interest in Value Retail generating net proceeds of £583m. Pro forma at 30 June 2024 reflecting only the disposal of the Group's interest in Value Retail; LTV was 24.7% and net debt:EBITDA was 5.3x.

 

ENDS

Hammerson plc

Investor Contact

Josh Warren, Hammerson, Director of Strategy, Commercial Finance and Investor Relations

 

 

 

+44 (0)20 7887 1053

MHP for Hammerson Media

Oliver Hughes

Ollie Hoare

 

+44 (0)7885 224 532

+44 (0)7817 458 804

 

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMGGKRNGDZM
Date   Source Headline
5th Jun 202010:00 amRNSHolding(s) in Company
4th Jun 202012:00 pmRNSHolding(s) in Company
1st Jun 202011:30 amRNSBlock listing Interim Review
29th May 202011:30 amRNSHolding(s) in Company
29th May 202010:04 amRNSDirector/PDMR Shareholding
27th May 202010:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSCEO succession planning
21st May 202010:00 amRNSHolding(s) in Company
15th May 202010:00 amRNSHolding(s) in Company
14th May 202010:15 amRNSHolding(s) in Company
14th May 20209:30 amRNSHolding(s) in Company
13th May 202010:15 amRNSHolding(s) in Company
12th May 20203:00 pmRNSHolding(s) in Company
12th May 202011:00 amRNSHolding(s) in Company
7th May 202011:30 amRNSHolding(s) in Company
6th May 20207:00 amRNSUpdate on disposal of retail parks portfolio
5th May 20204:00 pmRNSHolding(s) in Company
4th May 20209:30 amRNSHolding(s) in Company
28th Apr 20204:00 pmRNSResult of AGM
28th Apr 20203:00 pmRNSDirector/PDMR Shareholding
27th Apr 202011:00 amRNSArticles of Association
23rd Apr 20201:00 pmRNSUpdate on disposal of retail parks portfolio
21st Apr 20209:15 amRNSHolding(s) in Company
20th Apr 20203:45 pmRNSDirector/PDMR Shareholding
20th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20204:30 pmRNSHolding(s) in Company
7th Apr 20202:00 pmRNSHolding(s) in Company
7th Apr 202010:15 amRNSHolding(s) in Company
3rd Apr 20207:00 amRNS2020 Annual General Meeting
30th Mar 20207:00 amRNSCOVID-19 Update
26th Mar 20203:00 pmRNSDirector/PDMR Shareholding
26th Mar 20209:15 amRNSHolding(s) in Company
25th Mar 20201:00 pmRNSDirector/PDMR Shareholding
25th Mar 20208:00 amRNSUpdate on AGM and Remuneration
24th Mar 202010:15 amRNSHolding(s) in Company
23rd Mar 202010:15 amRNSHolding(s) in Company
20th Mar 202010:30 amRNSHolding(s) in Company
19th Mar 20203:00 pmRNSHolding(s) in Company
19th Mar 202010:00 amRNSHolding(s) in Company
19th Mar 20209:30 amRNSHolding(s) in Company
18th Mar 202011:00 amRNSHolding(s) in Company
17th Mar 202011:00 amRNSAnnual Report and Notice of AGM
17th Mar 202010:30 amRNSHolding(s) in Company
13th Mar 202012:00 pmRNSDirector/PDMR Shareholding
12th Mar 202010:30 amRNSHolding(s) in Company
12th Mar 20207:00 amRNSAppointment of General Counsel & Company Secretary
11th Mar 20203:50 pmRNSDirector/PDMR Shareholding
10th Mar 20202:30 pmRNSDirector/PDMR Shareholding
10th Mar 202011:00 amRNSDirector/PDMR Shareholding
9th Mar 202010:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.